ANovember 17, 2026

Tonight: measles in mothers and newborns, Texas’s long-delayed maternal death report, and more.

— Meghan McCarthy

MEASLES REACHES MOTHERS AND NEWBORNS

The U.S. has lost its measles elimination status after sustained spread of the virus. New CDC findings show what that resurgence means for pregnant women and newborns, The New York Times reports. From January 2025 through Sept. 28, 2026, 112 pregnant women caught measles; 26 were hospitalized for reasons other than labor, and 11 developed pneumonia. Of 19 babies born within two weeks of their mothers developing a rash, eight arrived early, and 13 newborns met the report’s definition of congenital measles. All but two women were unvaccinated or had unknown vaccination status. Babies infected before birth also face a higher risk of a rare, fatal brain disease that can appear years later. Pregnancy outcomes were unknown for half the women when the data were collected.

Starting Jan. 1, Illinois employers must provide reasonable accommodations for menopause-related conditions under a law that extends the state’s pregnancy protections to perimenopause and menopause. The law covers symptoms including hot flashes, sleep disruption, cognitive or mood changes, and bone loss, and requires employers to post a notice explaining workers’ rights. Accommodations can include flexible hours and changes to workplace temperature. Changes to the state’s menopause insurance coverage requirements follow in 2028. Philadelphia’s menopause accommodation requirements also take effect Jan. 1. Only 10% of employers surveyed by benefits firm NFP said they currently offer menopause accommodations.

TEXAS’S MATERNAL DEATH REPORT, FINALLY

Mental health conditions were the leading cause of pregnancy-related death in the cases reviewed for Texas’s maternal mortality report, released Friday after a delay of more than two months. The state recorded 20.5 maternal deaths per 100,000 live births in 2024, down from 23.5 in 2021 when COVID deaths were excluded. Among reviewed pregnancy-related deaths, the share attributed to suicide or homicide rose from 5% to 19%, and about three-quarters were judged potentially preventable. Using the report’s separate pregnancy-related mortality measure, Black women died at about 2.4 times the rate of white women. The report skips individual case reviews for 2022 and 2023, years that could have offered more information about deaths after the state’s near-total abortion ban, and never mentions abortion. State health officials say they skipped those years to bring reviews up to date, not because of the ban.

THE TRADE-OFF AFTER BREAST CANCER

Taking estrogen-blocking drugs consistently for five years was associated with a lower risk of dying but more diagnoses of heart disease risk factors over the decade after breast cancer diagnosis, according to a Kaiser Permanente study of around 8,400 postmenopausal women. Compared with women who started treatment but never took it consistently, five years of treatment was associated with an 11-percentage-point lower risk of dying from any cause. It was also associated with about a 9-point higher risk of high blood pressure, a 5-point higher risk of high cholesterol or triglycerides, and a 3-point higher risk of diabetes. Aromatase inhibitors were linked to all three conditions; tamoxifen was linked only to high blood pressure. Fewer than half the women stayed on treatment for at least five years. The researchers say heart health belongs in long-term breast cancer care.

NOT JUST A MATERNAL ISSUE

Whole-genome sequencing identified possible genetic explanations for pregnancy loss in about a quarter of 118 families with recurrent miscarriages that standard chromosome testing couldn’t explain, according to a study in Genome Medicine. Researchers sequenced DNA from mothers, fathers, and lost pregnancies, finding disease-causing or likely disease-causing variants in 18 families and uncertain findings in another 12. In 24 of those 30 families, variants were inherited from one or both parents, sometimes from a parent with few or no symptoms. “This is not just a maternal issue,” said UCSF’s Aleksandar Rajkovic. About 1 in 20 women experience more than one miscarriage. Sequencing isn’t standard care yet, insurance coverage varies, and larger studies are needed.

Maternie does the clicking so you don't have to. If this was useful, leave a rating below — it's the clearest signal we get.

What did you think of this edition?

Login or Subscribe to participate